Filings
| Filing | Date | Type | Filed with |
|---|
| GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS | Nov 20, 2026 | Other filings | HKEX |
|---|
| MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2026 | Nov 5, 2026 | Monthly return | HKEX |
|---|
| VOLUNTARY ANNOUNCEMENT - CSTONE AND KIMIA THERAPEUTICS ENTER CLINICAL DEVELOPMENT COLLABORATION TO ADVANCE A NOVEL DRUG CANDIDATE TARGETING REPAIR PATHWAYS CRITICAL FOR SOLID TUMOR SURVIVAL | Nov 3, 2026 | Operations update | HKEX |
|---|
| VOLUNTARY ANNOUNCEMENT - CSTONE ANNOUNCES MAJOR CLINICAL VALIDATION MILESTONE FOR CS2009 AT ESMO 2026: DATA FROM MORE THAN 300 PATIENTS SUPPORT MECHANISM, SAFETY AND BROAD ANTITUMOR ACTIVITY | Oct 25, 2026 | Other filings | HKEX |
|---|
| MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2026 | Oct 7, 2026 | Monthly return | HKEX |
|---|
| INTERIM REPORT 2026 | Sep 28, 2026 | Interim report | HKEX |
|---|
| VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTOR DR. JIANXIN YANG BY 496,000 SHARES, WITH ACCUMULATED PURCHASE TOTALING 14,210,500 SHARES | Sep 24, 2026 | Ownership change notice | HKEX |
|---|